- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Windlas Biotech Limited — Updates, 06-11-2025: Press Release
06-11-2025 | 06:50 pm
06-11-2025 | 06:50 pm
Windlas Biotech delivered strong H1FY26 results: Revenue Rs 432.5 Cr (+19.4% YoY), EBITDA Rs 55.1 Cr (+25.4% YoY), PAT Rs 35.5 Cr (+21.7% YoY). All verticals contributed to growth. Capacity enhancements like Injectables and Plant 6 expansion are on track for FY26.
No comments yet. Be the first to comment!